TrialHeart (British Cardiac Society)2024

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.

Yu-Ling Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.